923 related articles for article (PubMed ID: 27799004)
21. A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer.
van Velthoven R; Aoun F; Marcelis Q; Albisinni S; Zanaty M; Lemort M; Peltier A; Limani K
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):79-83. PubMed ID: 26597660
[TBL] [Abstract][Full Text] [Related]
22. Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.
Haglind E; Carlsson S; Stranne J; Wallerstedt A; Wilderäng U; Thorsteinsdottir T; Lagerkvist M; Damber JE; Bjartell A; Hugosson J; Wiklund P; Steineck G;
Eur Urol; 2015 Aug; 68(2):216-25. PubMed ID: 25770484
[TBL] [Abstract][Full Text] [Related]
23. Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis.
Park JW; Jang WS; Koh DH; Ham WS; Rha KH; Hong SJ; Choi YD
Yonsei Med J; 2018 Jul; 59(5):580-587. PubMed ID: 29869455
[TBL] [Abstract][Full Text] [Related]
24. High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes.
Palermo G; Totaro A; Sacco E; Foschi N; Gulino G; Racioppi M; Bassi P; Pinto F
Minerva Urol Nefrol; 2017 Feb; 69(1):93-100. PubMed ID: 28009150
[TBL] [Abstract][Full Text] [Related]
25. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
26. Effect of Prior Focal Therapy on Perioperative, Oncologic and Functional Outcomes of Salvage Robotic Assisted Radical Prostatectomy.
Nunes-Silva I; Barret E; Srougi V; Baghdadi M; Capogrosso P; Garcia-Barreras S; Kanso S; Tourinho-Barbosa R; Carneiro A; Sanchez-Salas R; Rozet F; Galiano M; Cathelineau X
J Urol; 2017 Nov; 198(5):1069-1076. PubMed ID: 28551444
[TBL] [Abstract][Full Text] [Related]
27. Salvage Hemiablation High Intensity Focused Ultrasound for unilateral radio-recurrent prostate cancer.
Aoun F; Albisinni S; Biaou I; Peltier A; Limani K; Roumeguère T; van Velthoven R
Prog Urol; 2019 Oct; 29(12):627-633. PubMed ID: 31400963
[TBL] [Abstract][Full Text] [Related]
28. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up.
Lantz A; Bock D; Akre O; Angenete E; Bjartell A; Carlsson S; Modig KK; Nyberg M; Kollberg KS; Steineck G; Stranne J; Wiklund P; Haglind E
Eur Urol; 2021 Nov; 80(5):650-660. PubMed ID: 34538508
[TBL] [Abstract][Full Text] [Related]
29. Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection.
Johnson DC; Yang JJ; Kwan L; Barsa DE; Mirak SA; Pooli A; Sadun T; Jayadevan R; Zhou S; Priester AM; Natarajan S; Bajgiran AM; Shakeri S; Sisk A; Felker ER; Raman SS; Marks LS; Reiter RE
Cancer; 2019 Sep; 125(17):2955-2964. PubMed ID: 31042322
[TBL] [Abstract][Full Text] [Related]
30. Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial.
Nyberg M; Hugosson J; Wiklund P; Sjoberg D; Wilderäng U; Carlsson SV; Carlsson S; Stranne J; Steineck G; Haglind E; Bjartell A;
Eur Urol Oncol; 2018 Oct; 1(5):353-360. PubMed ID: 31158073
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
[TBL] [Abstract][Full Text] [Related]
32. Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes.
Devos B; Al Hajj Obeid W; Andrianne C; Diamand R; Peltier A; Everaerts W; Van Poppel H; Van Velthoven R; Joniau S
World J Urol; 2019 Aug; 37(8):1507-1515. PubMed ID: 30666400
[TBL] [Abstract][Full Text] [Related]
33. Five-year Outcomes for a Prospective Randomised Controlled Trial Comparing Laparoscopic and Robot-assisted Radical Prostatectomy.
Porpiglia F; Fiori C; Bertolo R; Manfredi M; Mele F; Checcucci E; De Luca S; Passera R; Scarpa RM
Eur Urol Focus; 2018 Jan; 4(1):80-86. PubMed ID: 28753822
[TBL] [Abstract][Full Text] [Related]
34. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
35. Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.
Apfelbeck M; Chaloupka M; Schlenker B; Stief CG; Clevert DA
Clin Hemorheol Microcirc; 2019; 73(1):135-143. PubMed ID: 31561350
[TBL] [Abstract][Full Text] [Related]
36. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
37. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
[TBL] [Abstract][Full Text] [Related]
38. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU
Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750
[TBL] [Abstract][Full Text] [Related]
39. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological, functional, and immediate oncologic outcome assessment in men aged≤50 years with prostate cancer after robotic prostatectomy.
Samadi DB; Sebrow D; Hobbs AR; Bernstein AN; Brajtbord J; Lavery HJ; Jazayeri SB
Urol Oncol; 2017 Jan; 35(1):30.e17-30.e24. PubMed ID: 27567690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
